ECSP045322A - Formulaciones de un anhidrato en suspensión con hfa - Google Patents

Formulaciones de un anhidrato en suspensión con hfa

Info

Publication number
ECSP045322A
ECSP045322A EC2004005322A ECSP045322A ECSP045322A EC SP045322 A ECSP045322 A EC SP045322A EC 2004005322 A EC2004005322 A EC 2004005322A EC SP045322 A ECSP045322 A EC SP045322A EC SP045322 A ECSP045322 A EC SP045322A
Authority
EC
Ecuador
Prior art keywords
hfa
hid
formulations
suspension
hydroxidi
Prior art date
Application number
EC2004005322A
Other languages
English (en)
Spanish (es)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ECSP045322A publication Critical patent/ECSP045322A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
EC2004005322A 2002-03-28 2004-09-28 Formulaciones de un anhidrato en suspensión con hfa ECSP045322A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10214264A DE10214264A1 (de) 2002-03-28 2002-03-28 HFA-Suspensionsformulierungen eines Anhydrats

Publications (1)

Publication Number Publication Date
ECSP045322A true ECSP045322A (es) 2005-01-28

Family

ID=28050990

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004005322A ECSP045322A (es) 2002-03-28 2004-09-28 Formulaciones de un anhidrato en suspensión con hfa

Country Status (21)

Country Link
EP (1) EP1492498A2 (sr)
JP (1) JP5147158B2 (sr)
KR (1) KR101005717B1 (sr)
CN (1) CN1642525A (sr)
AU (1) AU2003221509B2 (sr)
BR (1) BR0308709A (sr)
CA (1) CA2479638C (sr)
DE (1) DE10214264A1 (sr)
EA (1) EA008610B1 (sr)
EC (1) ECSP045322A (sr)
HR (1) HRP20040890A2 (sr)
IL (1) IL163696A0 (sr)
ME (1) ME00246B (sr)
MX (1) MXPA04009338A (sr)
NO (1) NO20044004L (sr)
NZ (1) NZ536030A (sr)
PL (1) PL371295A1 (sr)
RS (1) RS52481B (sr)
UA (1) UA79776C2 (sr)
WO (1) WO2003082244A2 (sr)
ZA (1) ZA200405637B (sr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080007656A (ko) * 2005-05-02 2008-01-22 베링거 인겔하임 인터내셔날 게엠베하 티오트로피움 브로마이드의 신규한 결정질 형태
EP2085396A3 (en) * 2005-05-02 2009-11-25 Boehringer Ingelheim International Gmbh Novel crystalline forms of tiotropium bromide
SI3106149T1 (sl) * 2009-05-29 2020-07-31 Pearl Therapeutics, Inc. Sestavki za pljučno dostavo muskarinskih antagonistov z dolgotrajnim delovanjem in agonistov beta-2 adrenergičnega receptorja z dolgotrajnim delovanjem in povezani postopki in sistemi
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
AU2015201037C1 (en) * 2009-05-29 2017-07-27 Pearl Therapeutics, Inc. Respiratory delivery of active agents
HK1219059A1 (zh) 2013-03-15 2017-03-24 珍珠治疗公司 用於微粒晶体材料的状态调节的方法和系统
EP3922240B1 (en) * 2016-09-19 2023-06-21 Mexichem Fluor S.A. de C.V. Pharmaceutical composition comprising tiotropium bromide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
AU749697B2 (en) * 1998-08-04 2002-07-04 Jagotec Ag Medicinal aerosol formulations
GB0009605D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
GB0009606D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic combinations
GB0009592D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
DE10113366A1 (de) * 2001-03-20 2002-09-26 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Endothelinantagonisten
CA2436537C (en) * 2000-10-31 2009-05-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions comprising tiotropium salts and antihistamines
DE10111058A1 (de) * 2001-03-08 2002-09-12 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und NK¶1¶-Rezeptor-Antagonisten

Also Published As

Publication number Publication date
EA200401159A1 (ru) 2005-04-28
NO20044004L (no) 2004-10-05
JP2005527550A (ja) 2005-09-15
CA2479638C (en) 2011-01-04
YU86004A (sh) 2006-08-17
CN1642525A (zh) 2005-07-20
BR0308709A (pt) 2005-01-04
RS52481B (sr) 2013-02-28
KR101005717B1 (ko) 2011-01-05
MXPA04009338A (es) 2005-01-25
AU2003221509A1 (en) 2003-10-13
AU2003221509B2 (en) 2008-01-24
KR20040098022A (ko) 2004-11-18
DE10214264A1 (de) 2003-10-16
ME00246B (me) 2011-05-10
ZA200405637B (en) 2005-07-27
MEP47308A (en) 2011-02-10
EA008610B1 (ru) 2007-06-29
WO2003082244A3 (de) 2004-02-05
JP5147158B2 (ja) 2013-02-20
CA2479638A1 (en) 2003-10-09
UA79776C2 (en) 2007-07-25
IL163696A0 (en) 2005-12-18
PL371295A1 (en) 2005-06-13
EP1492498A2 (de) 2005-01-05
NZ536030A (en) 2006-07-28
HRP20040890A2 (en) 2005-06-30
WO2003082244A2 (de) 2003-10-09

Similar Documents

Publication Publication Date Title
BR0116444A (pt) Processo para a preparação de brometo de tiotrópio anticolinérgico
ES2134051T3 (es) Procedimiento para la preparacion de sildenafil.
MXPA03011197A (es) Benzoilsufonamidas y sulfonilbenzamidinas que se usan como agentes antitumorales.
NO20045235L (no) Tetrahydropyranylsyklopentyltetrahydropyridopyridinmodulatorer med kjemokinreseptoraktivitet
FI903331A0 (fi) Substituerade kinazolinoner, vilka aer anvaendbara som angiotensin-ii-antagonister.
JO2654B1 (en) Multiple aryl caroxa amides are useful as lipid - lowering agents
TW200738672A (en) Intermediated for the preparation of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
IL158485A (en) Spiropyrazole compounds
MX9304646A (es) Nuevas 7-(sustituido)-8-(sustituido)d-9-[(glicilo sustituido)amido]-6-desmetil-6-desoxitetraciclinasy metodo para su produccion.
GB0127903D0 (en) Improvements relating to organic compounds
MXPA03009602A (es) Analogos de nociceptina.
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
ECSP045322A (es) Formulaciones de un anhidrato en suspensión con hfa
SG136958A1 (en) Antagonistic analogs of gh-rh (2003)
ECSP045321A (es) Formulaciones en suspensión con hfa que contienen un anticolinérgico
MXPA04003755A (es) Endoprotesis vasculares.
MXPA05002639A (es) Hule de silicon.
DE60112325D1 (de) Cyclisierungsverfahrensschritt bei der herstellung von chinolonen und naphthyridinen
IL150310A0 (en) Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
BR9916460A (pt) Produção de ácido ascórbico usando levedura
ATE243362T1 (de) Phosphor-überzug für gasentladungslampen
GB2348423B (en) Novel anhydrofructose antioxidant
ES2093760T3 (es) Procedimiento para la obtencion de fosfinas terciarias.
GB9921578D0 (en) Omeprazole synthesis